ARCHIVES

Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Advisors: DepoCyt May Test Accelerated Approval Mechanism

November 27, 1998

Obey Explains Cuts In Control, Construction Funds; House Passes HEW Appropriations Bill

July 6, 1979

Study: Ibrutinib Lowers IgM, Bone Marrow Disease Burden

July 26, 2013

Rauscher, ACS Oppose Kennedy Bill, Defend NCI Special Authority, Say Funding Level Inadequate

May 11, 1979

Abstracts of ‘Most Newsworthy’ Papers

June 3, 1977

Continuing Resolution Averts Shutdown; Locks in Sequestration Cuts for NIH, NCI

March 22, 2013